BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37212267)

  • 41. Comparative study of oncologic outcome of laparoscopic nephroureterectomy and standard nephroureterectomy for upper urinary tract transitional cell carcinoma.
    Manabe D; Saika T; Ebara S; Uehara S; Nagai A; Fujita R; Irie S; Yamada D; Tsushima T; Nasu Y; Kumon H;
    Urology; 2007 Mar; 69(3):457-61. PubMed ID: 17382144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy.
    Freifeld Y; Ghandour R; Singla N; Woldu S; Bagrodia A; Lotan Y; Rapoport LM; Gazimiev M; Delafuente K; Kulangara R; Robyak H; Petros FG; Raman JD; Matin SF; Margulis V
    Urol Oncol; 2020 Sep; 38(9):737.e11-737.e16. PubMed ID: 32641241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors for Intravesical Recurrence Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A National Multicenter Analysis.
    Lee CH; Ku JY; Jeong CW; Ku JH; Kwak C; Kim HH; Tae BS; Choi SH; Kim HT; Kim TH; Kwon TG; Hwang EC; Jung SI; Kang TW; Kwon DD; Ha HK
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1055-e1061. PubMed ID: 28802888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
    Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
    BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Robotic Nephroureterectomy
    Kenigsberg AP; Smith W; Meng X; Ghandour R; Rapoport L; Bagrodia A; Lotan Y; Woldu SL; Margulis V
    J Endourol; 2021 Mar; 35(3):312-318. PubMed ID: 33081512
    [No Abstract]   [Full Text] [Related]  

  • 46. Significant predictors of contralateral upper tract recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Chen CS; Li JR; Yang CK; Cheng CL; Yang CR; Ou YC; Ho HC; Lin CY; Hung SC; Chen CC; Wang SC; Wang SS
    Int J Urol; 2022 Jan; 29(1):69-75. PubMed ID: 34608678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Chen H; Wang M; Weng T; Wei Y; Yang L; Ren K; Tang Z; Gou X
    Urol Int; 2022; 106(2):186-194. PubMed ID: 34492655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Single-docking robotic-assisted nephroureterectomy and extravesical bladder cuff excision without intraoperative repositioning: The technique and oncological outcomes.
    Ye H; Feng X; Wang Y; Chen R; Zhang C; Zhang W; Guo F; Wang Z; Fang Y; Wu Z; Yang Q; Yang B; Lü C; Wang L
    Asian J Surg; 2020 Oct; 43(10):978-985. PubMed ID: 31941594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma: the Cleveland Clinic experience.
    Gill IS; Sung GT; Hobart MG; Savage SJ; Meraney AM; Schweizer DK; Klein EA; Novick AC
    J Urol; 2000 Nov; 164(5):1513-22. PubMed ID: 11025694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
    Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
    J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does Xylinas' nomogram accurately predict intravesical recurrence risk after radical nephroureterectomy for primary upper urinary tract urothelial carcinoma when applied to Asian populations?
    Lai S; Wu P; Diao T; Seery S; Liu J; Hou H; Liu M; Wang J
    Jpn J Clin Oncol; 2021 Mar; 51(3):469-477. PubMed ID: 32734304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A multi-institutional retrospective study of open versus laparoscopic nephroureterectomy focused on the intravesical recurrence.
    Shimura S; Matsumoto K; Ikeda M; Moroo S; Koguchi D; Taoka Y; Hirayama T; Murakami Y; Utsunomiya T; Matsuda D; Okuno N; Irie A; Iwamura M
    Asia Pac J Clin Oncol; 2023 Feb; 19(1):71-78. PubMed ID: 35404494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hashimoto T; Nakashima J; Kashima T; Hirasawa Y; Shimodaira K; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Ohno Y; Ohori M; Tachibana M
    Int J Urol; 2017 Feb; 24(2):111-116. PubMed ID: 27875859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of diagnostic ureteroscopy before radical nephroureterectomy on intravesical recurrence in patients with upper tract urothelial cancer.
    Chung Y; Lee DH; Lee M; Kim H; Lee S; Hong SK; Byun SS; Lee SE; Oh JJ
    Investig Clin Urol; 2020 Mar; 61(2):158-165. PubMed ID: 32158966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prolonged pneumoperitoneum time is an independent risk factor for intravesical recurrence after laparoscopic radical nephroureterectomy in upper tract urothelial carcinoma.
    Shigeta K; Kikuchi E; Hagiwara M; Ando T; Mizuno R; Miyajima A; Nakagawa K; Oya M
    Surg Oncol; 2017 Mar; 26(1):73-79. PubMed ID: 28317587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
    Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
    BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Perioperative and oncologic outcomes of transperitoneal versus retroperitoneal laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma: a systematic review and pooled analysis of comparative outcomes.
    Zhu PY; Wang L; Li KP; Yin S; Chen XB
    World J Surg Oncol; 2023 May; 21(1):163. PubMed ID: 37248555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison between laparoscopic and open radical nephroureterectomy in a contemporary group of patients: are recurrence and disease-specific survival associated with surgical technique?
    Favaretto RL; Shariat SF; Chade DC; Godoy G; Kaag M; Cronin AM; Bochner BH; Coleman J; Dalbagni G
    Eur Urol; 2010 Nov; 58(5):645-51. PubMed ID: 20724065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Upper urinary tract recurrence following bladder cancer therapy: a review of surveillance and management.
    Naser-Tavakolian A; Ghodoussipour S; Djaladat H
    Curr Opin Urol; 2019 May; 29(3):189-197. PubMed ID: 30762673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.